van Dongen GA - Search Results

1

Immuno-PET: a navigator in monoclonal antibody development and applications.

van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR. van Dongen GA, et al. Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379. Oncologist. 2007. PMID: 18165614 Free article. Review.

2

Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.

van Dongen GA, Leverstein H, Roos JC, Quak JJ, van den Brekel MW, van Lingen A, Martens HJ, Castelijns JA, Visser GW, Meijer CJ, et al. van Dongen GA, et al. Among authors: van den brekel mw, van lingen a. Cancer Res. 1992 May 1;52(9):2569-74. Cancer Res. 1992. PMID: 1568225

3

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.

Gerretsen M, Visser GW, Brakenhoff RH, van Walsum M, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: van walsum m, van dongen ga. Cell Biophys. 1994;24-25:135-42. doi: 10.1007/BF02789224. Cell Biophys. 1994. PMID: 7736517

4

Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.

Quak J, van Dongen G. Quak J, et al. Eur Arch Otorhinolaryngol. 1994;251(1):1-5. doi: 10.1007/BF00175949. Eur Arch Otorhinolaryngol. 1994. PMID: 8179860 Review.

5

Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.

Visser GW, Gerretsen M, Herscheid JD, Snow GB, van Dongen G. Visser GW, et al. J Nucl Med. 1993 Nov;34(11):1953-63. J Nucl Med. 1993. PMID: 8229241 Free article.

6

186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.

Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: van walsum m, van dongen ga. Cancer Res. 1993 Aug 1;53(15):3524-9. Cancer Res. 1993. PMID: 8339258

7

MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.

Schrijvers AH, Quak JJ, Uyterlinde AM, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Among authors: van walsum m, van dongen ga. Cancer Res. 1993 Sep 15;53(18):4383-90. Cancer Res. 1993. PMID: 8364934

8

Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.

van Gog FB, Visser GW, Klok R, van der Schors R, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: van dongen ga, van der schors r. J Nucl Med. 1996 Feb;37(2):352-62. J Nucl Med. 1996. PMID: 8667076 Free article.

9

High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.

van Gog FB, Visser GW, Stroomer JW, Roos JC, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: van dongen ga. Cancer. 1997 Dec 15;80(12 Suppl):2360-70. Cancer. 1997. PMID: 9406684

10

Synthesis and evaluation of 99mTc/99Tc-MAG3-biotin conjugates for antibody pretargeting strategies.

van Gog FB, Visser GW, Gowrising RW, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: van dongen ga. Nucl Med Biol. 1998 Oct;25(7):611-9. doi: 10.1016/s0969-8051(98)00022-5. Nucl Med Biol. 1998. PMID: 9804042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters